IP Library Granted Patent US 12,365,891
Granted Patent B2
US 12,365,891 · App. 17/269,182 · Granted Jul 22, 2025

Methods and compositions for nucleic acid isolation

Inventors: Vera Baraznenok (Sunnyvale, CA); Alex I. Kutyavin (Sunnyvale, CA); Oliver Z. Nanassy (Sunnyvale, CA); Dmitri Sergueev (Sunnyvale, CA); Alexander A. Gall (Sunnyvale, CA)
Assignee: CEPHEID
C12N15/1006C12Q1/6806C08B37/0045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,365,891
App. No.
17/269,182
Granted
Jul 22, 2025
Kind
B2
Abstract

Methods and compositions for isolation of nucleic acids from biological samples are provided.

Claims (60)

1. A method for isolation of a nucleic acid from a sample comprising a nucleic acid, comprising:

(a) contacting a sample comprising a nucleic acid with an aqueous composition comprising a polysaccharide comprising one or more repeating units having the structure of Formula II:

or a stereoisomer, a salt, a tautomer, or a combination thereof, wherein:

R 2 and R 3 are independently H, substituted C 1 -C 8 alkyl, substituted C 3 -C 8 cycloalkyl, substituted C 3 -C 8 heterocycloalkyl, or substituted C 2 -C 20 heteroalkyl; and

(b) concentrating the nucleic acid on a solid support thereby isolating the nucleic acid, wherein the method is performed in a cartridge.

2. The method of claim 1 , wherein the polysaccharide further comprises one or more repeating units of Formula (III):

or a stereoisomer, a salt, a tautomer, or a combination thereof, wherein R 3 is H, CH 3 , CH 2 CH 2 NH 2 , CH 2 CH 2 N(CH 3 ) 2 , CH 2 CH 2 OH, (CH 2 ) 2 O(CH 2 ) 2 NH 2 , or CH 2 CH 2 NHCH 2 CH 2 NH 2 .

3. The method of claim 1 , wherein the polysaccharide comprises one or more repeating units having the structure of Formula VI:

or a stereoisomer, a salt, a tautomer, or a combination thereof, wherein:

n is 0, 1, 2, or 3;

R 4 is H or C 1 -C 3 alkyl;

X, at each occurrence, is independently C 2 -C 4 alkylene or C 4 -C 6 heteroalkylene;

Y is a C 2 -C 3 alkylene or C 4 -C 6 heteroalkylene; and

R 5 and R 6 are independently H or C 1 -C 3 alkyl.

4. The method of claim 1 , wherein the polysaccharide comprises one or more repeating units having the structure of Formula V:

or a stereoisomer, a salt, a tautomer, or a combination thereof, wherein:

n is 0, 1, 2, or 3;

m, at each occurrence, is independently 2, 3, or 4;

p is 2, 3, or 4;

R 4 is H or C 1 -C 3 alkyl; and

R 5 and R 6 are independently H or C 1 -C 3 alkyl.

5. The method of claim 1 , wherein the polysaccharide comprises one or more repeating units represented by Formula VI, Formula VII, or Formula VIII:

or a stereoisomer, a salt, a tautomer, or combination thereof.

6. The method of claim 1 , wherein the polysaccharide is present in the aqueous composition at a concentration from about 0.1 μg/mL to about 1000 μg/mL.

7. The method of claim 1 , wherein the polysaccharide has a relative molecular weight between about 120 kDa and about 500 kDa.

8. The method of claim 1 , wherein the nucleic acid is concentrated by centrifugation, precipitation, or a combination thereof.

9. The method of claim 1 , wherein the nucleic acid is concentrated by precipitation on a solid support.

10. The method of claim 1 , wherein the solid support comprises a material selected from silica, glass, ethylenic backbone polymer, mica, polycarbonate, zeolite, titanium dioxide, or a combination thereof.

11. The method of claim 1 , wherein the solid support is a magnetic bead, glass bead, cellulose filter, polycarbonate filter, polytetrafluoroethylene filter, polyvinylpyrrolidone filter, polyethersulfone filter, or glass filter.

12. The method of claim 1 , wherein the method further comprises washing and/or eluting the nucleic acid concentrated on the solid support with a wash agent, an eluting agent, or a comniation thereof.

13. The method of claim 1 , wherein the aqueous composition further comprises one or more of a lysis agent, a chaotropic agent, a salt, a buffering agent, a surfactant, or a defoaming agent.

14. The method of claim 1 , wherein the sample comprising nucleic acid is or comprises blood, plasma, serum, semen, spinal fluid, tissue biopsy, tear, urine, stool, saliva, smear preparation, bacterial culture, mammalian cell culture, viral culture, human cell, bacteria, extracellular fluid, PCR reaction mixture, cell lysate preparation, or in vitro nucleic acid modification reaction mixture.

15. A method for isolation of a nucleic acid from a sample comprising a nucleic acid, comprising:

(a) contacting a sample comprising a nucleic acid with an aqueous composition comprising a polysaccharide comprising one or more repeating units having the structure of Formula II:

or a stereoisomer, a salt, a tautomer, or a combination thereof, wherein:

R 2 and R 3 are independently H, substituted C 1 -C 8 alkyl, substituted C 3 -C 8 cycloalkyl, substituted C 3 -C 8 heterocycloalkyl, or substituted C 2 -C 20 heteroalkyl; and

(b) concentrating the nucleic acid on a solid support thereby isolating the nucleic acid, further comprising contacting the sample with a lysis buffer prior to contacting the sample with the aqueous composition.

16. The method of claim 15 , wherein the polysaccharide comprises one or more repeating units having the structure of Formula IV:

or a stereoisomer, a salt, a tautomer, or a combination thereof, wherein:

n is 0, 1, 2, or 3;

R 4 is H or C 1 -C 3 alkyl;

X, at each occurrence, is independently C 2 -C 4 alkylene or C 4 -C 6 heteroalkylene;

Y is a C 2 -C 3 alkylene or C 4 -C 6 heteroalkylene; and

R 5 and R 6 are independently H or C 1 -C 3 alkyl.

17. The method of claim 15 , wherein the polysaccharide comprises one or more repeating units represented by Formula VI, Formula VII, or Formula VIII:

or a stereoisomer, a salt, a tautomer, or combination thereof.

18. A method for detecting a nucleic acid in a sample, comprising:

(a) contacting the sample with an aqueous composition comprising a polysaccharide comprising one or more repeating units having the structure of Formula II:

or a stereoisomer, a salt, a tautomer, or a combination thereof, wherein:

R 2 and R 3 are independently H, substituted C 1 -C 8 alkyl, substituted C 3 -C 8 cycloalkyl, substituted C 3 -C 8 heterocycloalkyl, or substituted C 2 -C 20 heteroalkyl;

(b) concentrating the nucleic acid; and

(c) detecting the nucleic acid,

wherein detecting the nucleic acid comprises amplifying the nucleic acid by polymerase chain reaction.

19. The method of claim 18 , wherein the polysaccharide comprises one or more repeating units having the structure of Formula IV:

or a stereoisomer, a salt, a tautomer, or a combination thereof, wherein:

n is 0, 1, 2, or 3;

R 4 is H or C 1 -C 3 alkyl;

X, at each occurrence, is independently C 2 -C 4 alkylene or C 4 -C 6 heteroalkylene;

Y is a C 2 -C 3 alkylene or C 4 -C 6 heteroalkylene; and

R 5 and R 6 are independently H or C 1 -C 3 alkyl.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2024
From: BARAZNENOK, VERA; KUTYAVIN, ALEX I.; NANASSY, OLIVER Z.; SERGUEEV, DMITRI; GALL, ALEXANDER A.
To: CEPHEID
Reel/Frame 067362/0649 →
Continuity (2)
Provisional Application 62765013 · Aug 17, 2018
Related Publication 20210324372A1 · Oct 21, 2021
References Cited (72)
US 5384400A · Crescenzi · 1995 [cited by applicant]
US 5763186A · Ludtke · 1998 [cited by applicant]
US 6374684B1 · Dority · 2002 [cited by applicant]
US 7125842B2 · Kawabe · 2006 [cited by applicant]
US 9663779B2 · Fabis et al. · 2017 [cited by applicant]
US 11819584B2 · Kutyavin et al. · 2023 [cited by applicant]
US 20040191790A1 · Tomassen · 2004 [cited by applicant]
US 20050119450A1 · Wang · 2005 [cited by examiner]
US 20050130196A1 · Hofstadler · 2005 [cited by applicant]
US 20050163825A1 · Naidu · 2005 [cited by applicant]
US 20060127991A1 · Christensen · 2006 [cited by applicant]
US 20080317666A1 · Fattal · 2008 [cited by examiner]
US 20110054161A1 · Bitner · 2011 [cited by applicant]
US 20110117628A1 · Hillebrand · 2011 [cited by applicant]
US 20120245337A1 · Fabis et al. · 2012 [cited by applicant]
US 20130072381A1 · Trudsoe · 2013 [cited by applicant]
US 20140011201A1 · Richmond · 2014 [cited by applicant]
US 20140243216A1 · Fabis et al. · 2014 [cited by applicant]
US 20150093755A1 · Zhao · 2015 [cited by applicant]
US 20150275269A1 · Li et al. · 2015 [cited by applicant]
US 20170320764A1 · De Boer · 2017 [cited by applicant]
US 20170335312A1 · Hillebrand · 2017 [cited by applicant]
US 20210238583A1 · Kutyavin et al. · 2021 [cited by applicant]
AU 2015201538 · 2015 [cited by applicant]
CN 1680421 · 2005 [cited by applicant]
CN 1798570 · 2006 [cited by applicant]
CN 101018870 · 2007 [cited by applicant]
CN 101232807 · 2008 [cited by applicant]
CN 101573144 · 2009 [cited by applicant]
CN 103333870 · 2013 [cited by applicant]
CN 107141369 · 2017 [cited by applicant]
CN 107690481 · 2018 [cited by applicant]
CN 108219026 · 2018 [cited by applicant]
CN 111868253 · 2020 [cited by applicant]
CN 113015800A · 2021 [cited by applicant]
CN 113056291 · 2021 [cited by applicant]
CN 113056291A · 2021 [cited by applicant]
DE 69321215 · 1999 [cited by applicant]
EP 1613733 · 2006 [cited by applicant]
JP 2012513385A · 2012 [cited by applicant]
JP 2013502934 · 2013 [cited by applicant]
JP 2013502934A · 2013 [cited by applicant]
JP 2018518150 · 2018 [cited by applicant]
WO 2001038516 · 2001 [cited by applicant]
WO 2004005352 · 2004 [cited by applicant]
WO WO2010138074A1 · 2010 [cited by examiner]
WO 2011151428A1 · 2011 [cited by applicant]
WO WO2015082495A1 · 2015 [cited by examiner]
WO 2015120445 · 2015 [cited by applicant]
Rubinstein et al., “In Vitro Evaluation of Calcium Pectinate: A Potential Colon-Specific Drug Delivery Carrier” Pharmaceutical Research vol. 10 No. 2 pp. 258-263 (Year: 1993). [cited by examiner]
Khaled et al., “One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA” Biomaterials vol. 87 pp. 57-68, DOI: 10.1016/j.biomaterials.2016.01.052 (Year: 2016). [cited by examiner]
Prestwich, “Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine” Journal of Controlled Release vol. 155 pp. 193-199, DOI: 10.1016/j.jconrel.2011.04.007 (Year: 2011… [cited by examiner]
First Examination Report mailed Jul. 5, 2023, in corresponding Indian Application No. 202137010967, filed Aug. 16, 2019, 11 pages. [cited by applicant]
Notice of Reasons for Refusal mailed Aug. 8, 2023, in corresponding Japanese Application No. 2021-507772, filed Aug. 16, 2019, 7 pages. [cited by applicant]
Office Action mailed Dec. 6, 2023, in corresponding Canadian Application No. 3,109,805, filed Aug. 16, 2019, 4 pages. [cited by applicant]
Notice of Reasons for Refusal mailed Jan. 19, 2024, in corresponding Japanese Application No. 2021-507772, filed Aug. 16, 2019, 8 pages. [cited by applicant]
European Patent Office, International Search Report issued in PCT/US2019/046908, Nov. 15, 2019, 5 pages. [cited by applicant]
European Patent Office, Written Opinion issued in PCT/US2019/046908, Nov. 15, 2019, 5 pages. [cited by applicant]
The International Bureau of WIPO, International Preliminary Report on Patentability issued in PCT/US2019/046908, Feb. 23, 2021, 6 pages. [cited by applicant]
Kunal R. Pandit, et al., “Capture and Direct Amplification of DNA on Chitosan Microparticles in a Single PCR-Optimal Solution,” Analytical Chemistry, vol. 87, No. 21, Oct. 13, 2015, pp. 11022-11029. [cited by applicant]
First Office Action mailed Jun. 26, 2024, issued in the corresponding Chinese Application No. 201980065415.8; 9 pages. [cited by applicant]
Second Office Action, Chinese Application No. 2019800654158, dated Jan. 9, 2025, 10 pages. [cited by applicant]
Marcello Lenucci et al., Do Polyamines, Contribute to Plant Cell Wall Assembly by Forming Amide Bonds With Pectins?, Phytochemistry, vol. 66, 2005, pp. 2581-2594. [cited by applicant]
U.S. Appl. No. 17/269,198—European Patent Office, International Search Report issued in International Application No. PCT/US2019/046912, Oct. 29, 2019, 4 pages. [cited by applicant]
U.S. Appl. No. 17/269,198—European Patent Office, Written Opinion of the International Searching Authority issued in International Application No. PCT/US2019/046912, Oct. 29, 2019, 5 pages. [cited by applicant]
U.S. Appl. No. 17/269,198—The International Bureau of WIPO, International Preliminary Report on Patentability issued in International Application PCT/US2019/046912, Feb. 23, 2021, 6 pages. [cited by applicant]
Der-Zen Liu, et al., “Immonbilized Zinc Affinity Chromatography of Pectin Hydroxamic Acids for Purification of Trypsin Inhibitors from Soybean and Sweet Potato, ” Journal of Agricultural and Food Chemisty, 2005, vol. 53… [cited by applicant]
U.S. Appl. No. 17/269,198—Notice of Reasons For Refusal mailed Aug. 15, 2023, issued in corresponding Japanese Application No. 2021-507751, filed Aug. 16, 2019, 7 pages. [cited by applicant]
U.S. Appl. No. 17/269,198—Office Action mailed Jun. 25, 2024, issued in corresponding Chinese Application No. 2019800654586, filed Aug. 16, 2019, 12 pages. [cited by applicant]
Fischer, M. et al., Efficacy Assessment of Nucleic Acid Decontamination Reagents Used in Molecular Diagnostics Laboratories, PLOS One, Jul. 13, 2016. [cited by applicant]
Gerba, C.P. et al., Microbiological Hazards of Household Toilets: Droplet Production and the Fate of Residual Organisms, Applied Microbiology, vol. 30, No. 2, pp. 229-237, Aug. 1975. [cited by applicant]
Gibbons, S.M. et al., Ecological Succession and Viability of Human-Associated Microbiota on Restoom Surfaces, Applied and Enviromental Microbiology, vol. 81, No. 2, pp. 765-773, Jan. 2015. [cited by applicant]